COGT
Price
$4.97
Change
+$0.25 (+5.30%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
535.13M
96 days until earnings call
IDYA
Price
$18.18
Change
+$0.35 (+1.96%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.55B
96 days until earnings call
Ad is loading...

COGT vs IDYA

Header iconCOGT vs IDYA Comparison
Open Charts COGT vs IDYABanner chart's image
Cogent Biosciences
Price$4.97
Change+$0.25 (+5.30%)
Volume$23.03K
Capitalization535.13M
IDEAYA Biosciences
Price$18.18
Change+$0.35 (+1.96%)
Volume$34.09K
Capitalization1.55B
COGT vs IDYA Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. IDYA commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and IDYA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (COGT: $4.72 vs. IDYA: $17.83)
Brand notoriety: COGT and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 83% vs. IDYA: 105%
Market capitalization -- COGT: $535.13M vs. IDYA: $1.55B
COGT [@Biotechnology] is valued at $535.13M. IDYA’s [@Biotechnology] market capitalization is $1.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while IDYA’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • IDYA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, COGT is a better buy in the short-term than IDYA.

Price Growth

COGT (@Biotechnology) experienced а -9.40% price change this week, while IDYA (@Biotechnology) price change was -11.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.88%. For the same industry, the average monthly price growth was +15.29%, and the average quarterly price growth was -13.75%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-3.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.56B) has a higher market cap than COGT($535M). IDYA YTD gains are higher at: -30.623 vs. COGT (-39.487). COGT has higher annual earnings (EBITDA): -271.59M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. COGT (287M). COGT has less debt than IDYA: COGT (17.5M) vs IDYA (19.2M). IDYA has higher revenues than COGT: IDYA (7M) vs COGT (0).
COGTIDYACOGT / IDYA
Capitalization535M1.56B34%
EBITDA-271.59M-323.14M84%
Gain YTD-39.487-30.623129%
P/E RatioN/AN/A-
Revenue07M-
Total Cash287M676M42%
Total Debt17.5M19.2M91%
FUNDAMENTALS RATINGS
COGT vs IDYA: Fundamental Ratings
COGT
IDYA
OUTLOOK RATING
1..100
2120
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
7565
SMR RATING
1..100
9649
PRICE GROWTH RATING
1..100
9063
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (61) in the null industry is in the same range as COGT (82) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

IDYA's Profit vs Risk Rating (65) in the null industry is in the same range as COGT (75) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

IDYA's SMR Rating (49) in the null industry is somewhat better than the same rating for COGT (96) in the Miscellaneous industry. This means that IDYA’s stock grew somewhat faster than COGT’s over the last 12 months.

IDYA's Price Growth Rating (63) in the null industry is in the same range as COGT (90) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

IDYA's P/E Growth Rating (100) in the null industry is in the same range as COGT (100) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTIDYA
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBVLX16.810.07
+0.42%
Bridge Builder Large Cap Value
DRLAX8.54N/A
N/A
BNY Mellon Developed Markets RE Scs - A
MRRFX16.06N/A
N/A
BlackRock Mid-Cap Value R
FFALX15.84N/A
N/A
Franklin Global Allocation A
SIPIX28.85N/A
N/A
SEI Mid-Cap I (SIMT)

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+0.43%
SPHDF - COGT
63%
Loosely correlated
N/A
XNCR - COGT
53%
Loosely correlated
-5.61%
IDYA - COGT
52%
Loosely correlated
+0.45%
ETNB - COGT
51%
Loosely correlated
-1.03%
ARWR - COGT
49%
Loosely correlated
-0.15%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with RCKT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.45%
RCKT - IDYA
58%
Loosely correlated
+6.18%
IMNM - IDYA
56%
Loosely correlated
-2.56%
NTLA - IDYA
55%
Loosely correlated
+0.55%
KRYS - IDYA
55%
Loosely correlated
-1.91%
XENE - IDYA
54%
Loosely correlated
+0.43%
More